Educational content about cannabinoid science, not medical advice. Consult a healthcare professional before combining CBD products with medication. Our age policy
CBCA: Hemp's Third Acid From CBGA

Definition
Three acids come out of one. CBCA, or cannabichromenic acid, is the third of them: hemp builds it from CBGA using its own synthase enzyme, the same starting acid that also leads to THCA and CBDA [1]. Take one carboxyl group away as carbon dioxide, and the name on the molecule shortens to CBC.
One starting acid, three finish lines
| Point | What is on record |
|---|---|
| CBGA, cannabigerolic acid | The starting acid of the whole branch. Fellermeier and Zenk showed in 1998 that a hemp transferase moves a prenyl group onto olivetolate, and the product of that single step is CBGA, described in their work as the precursor of the plant's other cannabinoids [1]. |
| Olivetolate | The partner molecule in that reaction. On its own it is not a cannabinoid. Joined with a prenyl group by the transferase, it becomes the acid everything else in the branch is built from [1]. |
| Three synthase enzymes | The branch point. Three enzymes take the same substrate, and each returns one acid: THCA, CBDA or CBCA [1]. The input never changes. The enzyme does. |
| CBCA, cannabichromenic acid | The third acid on that list, and the molecule sitting directly before CBC. In broader constituent surveys it shows up in two roles at once, as a precursor and as a compound catalogued in the plant [2]. |
| THCA and CBDA | The other two products of the same branch. They share CBCA's origin in CBGA and the same before-and-after naming, which is why the three acids are usually listed together [1]. |
| The final letter A | A naming convention, not a grade. It marks the acid form the living plant makes: THCA before THC, CBDA before CBD, CBCA before CBC. |
| Decarboxylation | The step between the two names. A carboxyl group leaves the molecule as carbon dioxide, the carbon skeleton stays, and CBCA reads as CBC afterwards. |
| Gaoni and Mechoulam, 1966 | Cannabichromene was reported in hashish and written up as a new constituent of that material [3]. The record is for the neutral compound, downstream of CBCA. |
| ElSohly and Slade, 2005 | A survey of what the plant actually contains. The conclusion those chemists reached was a complex mixture rather than a short list, with CBD, THC and CBC among the named compounds, each preceded by an acid form [2]. |
| Where the research sits | Published attention has mostly followed the neutral cannabinoids. CBCA appears in the wider literature as a precursor and as a catalogued plant constituent [2] rather than as a subject of its own. |
| Cibdol 2.0 oils | The CBC content is standardised to a specified figure instead of following whatever a given harvest delivered. The CBC in the bottle began as CBCA in the plant. |
| Working since 2014 | Cibdol has been formulating and analysing cannabinoids since 2014. One standard sits behind that: know what is in the bottle, then state it plainly. |
| What CBCA is not | Not a variant of CBC, not a stronger version of it, and not a separate additive. It is the same carbon skeleton with one carboxyl group still attached. |
Same substrate, three possible products
A synthase is an enzyme that builds a molecule. Hemp has three of them working on one shared raw material, and that material is CBGA. Fellermeier and Zenk traced how it gets made in 1998: a hemp transferase carries a prenyl group onto olivetolate, and CBGA comes out of that reaction, described in their paper as the precursor of the plant's other cannabinoids [1].
Then the path splits three ways. Same substrate in every case. Out comes THCA, or CBDA, or CBCA, and which one it is depends on the enzyme that got there [1]. There is no halfway molecule. One enzyme, one acid, one name.
Anyone reading a cannabinoid list for the first time meets that final letter A a lot. It is not a strength marker and not a product variant. It marks the acid form, the version the living plant assembles: THCA before THC, CBDA before CBD, CBCA before CBC.
CBCA is the third of the three, and the quietest of them. Not because it hides in the plant, but because published work has largely followed the neutral cannabinoids. In the constituent literature, CBCA turns up in two roles: precursor, and catalogued plant compound [2]. ElSohly and Slade put the general picture plainly in 2005, describing plant cannabinoid content as a complex mixture rather than a short list [2]. CBD, THC and CBC all sit in that survey, and each has an acid form standing in front of it.
Read in the order the chemistry actually runs, the branch fits into a handful of lines:
- Olivetolate plus a prenyl group, joined by a hemp transferase, gives CBGA [1].
- CBGA is the shared starting acid, named in the 1998 work as the precursor of the plant's other cannabinoids [1].
- Three synthases work on it, and the documented outputs are THCA, CBDA and CBCA [1].
- CBCA is the acid that stands directly before CBC, one carboxyl group away from it.
- Decarboxylation is that step: the carboxyl group leaves as carbon dioxide.
- Cannabichromene itself was reported in hashish by Gaoni and Mechoulam in 1966 and written up as a new constituent [3].
- Constituent surveys list CBCA among the compounds the plant carries, not as a footnote to CBC [2].
One carboxyl group less, one new name
Decarboxylation sounds heavier than it is. A carboxyl group, the acidic part of the molecule, breaks away and leaves as carbon dioxide. The rest of the structure stays where it was. What changes is the name and one small piece of the chemistry, which is why CBCA and CBC are not two separate compounds in any real sense. They are the same skeleton, before and after.
That is also why the plant's inventory and a finished extract's inventory read differently. In a growing plant, the acid names dominate: THCA, CBDA, CBCA. By the time material has been processed, the neutral names carry the numbers. When Gaoni and Mechoulam described cannabichromene in 1966, they were working with hashish, processed plant material, and they recorded the compound as a new constituent of it [3]. The acid form is what the enzymes make; the neutral form is what tends to get measured.
Search for CBCA and most of what comes back will be about CBC. There is a reason for that, and it is not marketing. Research has concentrated on the neutral cannabinoids, so CBCA appears in the wider literature mainly as a precursor and as a catalogued constituent of the plant [2] rather than as the subject of its own body of work. The honest position is that the branch is well documented and the acid itself is thinly studied.
On a Cibdol 2.0 oil, the CBC content is standardised to a specified figure rather than left to whatever a harvest happened to deliver. That figure refers to CBC, the neutral form, and the CBC in the bottle traces straight back to CBCA in the plant. Nothing exotic sits between the two, only the loss of a carboxyl group as carbon dioxide.
Cibdol has been working with cannabinoids since 2014, back when CBD still needed explaining line by line. The standard behind that has not moved: know what is in the bottle, then say so in words a reader can check. Cannabinoid names are long, the chemistry is compact, and the useful part for anyone reading a label is short. Acid form in the plant. Neutral form in the analysis. One step in between, with a name.
Eight steps from plant molecule to label line
- Start with the transferase step. Fellermeier and Zenk documented a hemp transferase attaching a prenyl group to olivetolate, and the output of that reaction is CBGA [1]. Every acid discussed here begins at that point, so it is worth fixing before the names start multiplying.
- Register the branch. From CBGA, three synthase enzymes each produce one acid: THCA, CBDA and CBCA [1]. Same substrate for all three. The enzyme decides the product, which is why the three acids belong in one conversation rather than three.
- Give CBCA its full name once. Cannabichromenic acid is the third product of that branch, and the molecule standing immediately before CBC. Once the full name has been read aloud, the abbreviation stops looking like a typo of something else.
- Watch the letter A. In cannabinoid naming, a trailing A means acid form, not potency and not a variant. THCA, CBDA and CBCA are the plant-made versions of THC, CBD and CBC. Same skeletons, one group extra.
- Follow the decarboxylation. The carboxyl group leaves the molecule as carbon dioxide, and CBCA reads as CBC from that point on. This is the single chemical event separating the two names, and it explains why both appear in the same discussion.
- Check the 1966 record. Gaoni and Mechoulam reported cannabichromene in hashish and labelled it a new constituent of that material [3]. It is the neutral compound that was documented there, which sets the historical starting point for CBC rather than for CBCA.
- Place CBCA in the constituent catalogue. ElSohly and Slade described plant cannabinoid content as a complex mixture rather than a short list, with CBD, THC and CBC among the named compounds [2]. CBCA sits in that same body of work as a precursor and a catalogued constituent.
- Then read the bottle. On a Cibdol 2.0 oil, CBC is standardised to a specified figure instead of tracking the harvest, and that CBC started as CBCA in the plant. Since 2014, the working rule has stayed the same: know the contents, state them plainly.
Frequently Asked Questions
4 questionsWhere does CBCA come from inside the hemp plant?
What actually leaves the molecule when CBCA becomes CBC?
Why is there so much more written about CBC than about CBCA?
Does the CBC figure on a Cibdol 2.0 oil change from harvest to harvest?
About this article
Luke Sholl has been writing about cannabinoids, CBD, and the broader benefits of nature since 2011. His background includes first-hand cannabis cultivation experience spanning the full seed-to-harvest lifecycle across so
This wiki article was drafted with AI assistance and reviewed by Luke Sholl, CBD & wellness writer. Editorial oversight by Joshua Askew.
Medical disclaimer. This content is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before use of any substance.
Last reviewed August 26, 2026
References (3)
- [1]Fellermeier, M. and Zenk, M.H. (1998). Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol. DOI: https://doi.org/10.1016/s0014-5793(98)00450-5
- [2]ElSohly, M.A. and Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. DOI: https://doi.org/10.1016/j.lfs.2005.09.011
- [3]Gaoni, Y. and Mechoulam, R. (1966). Cannabichromene, a new active principle in hashish. DOI: https://doi.org/10.1039/c19660000020
Related Articles

Does CBG Make You Sleepy? What's Actually on Record
The idea that cannabigerol brings on drowsiness is widely repeated, but the 2021 review by Nachnani and Barrett describes receptor sites rather than sensations in volunteers. The same thing happened to CBN, and Corroon traced it in 2021.

THCA vs THC: A Single Carboxyl Group Apart
One carboxyl group separates the acid form found in the plant from the neutral compound most people talk about. Here is what happens when it goes, and why two lab figures from one plant are not a contradiction.

Broad Spectrum CBD: What The Term Covers
Broad spectrum sits between full spectrum and isolate, and it's the one name on that list with no legal definition behind it. Here's what the term commits to, what research covers, and what our own range holds.

THCP: A Cannabinoid With Two Extra Carbons
Tetrahydrocannabiphorol turned up in an Italian medicinal cannabis variety in December 2019, in work led by Cinzia Citti [1]. Here is what that report actually records, and where our own range sits.

CBD Research: What the Human Data Covers
A calm look at what has actually been measured in cannabidiol studies, where the published record thins out, and what to check before you believe a claim.

Serotonin, 5-HT and the One Cannabinoid Link on Record
5-HT is not one receptor but at least seven families of them, each split into subtypes. Here is what that means for reading claims, and what the 2005 in vitro report on cannabidiol at 5-HT1a does and does not cover [1].

PEA and Anandamide: A Family Resemblance in Chemistry
Palmitoylethanolamide shares a chemical class and a clearance route with anandamide. Here is what that family resemblance settles, and what it deliberately leaves open.

The Endocannabinoid System in Six Papers, 1964 to 1995
The structure of THC was published in 1964, the first cannabinoid receptor in 1990, anandamide in 1992. Six reports, thirty-one years, and a name that runs backwards.

2016: What Clinical Endocannabinoid Deficiency (CECD) Actually Means
CECD is a testable idea about underactive endocannabinoid signalling, set out most clearly in a 2016 paper by Russo [1]. Here is what that paper names, and where the record stops.



















